• Protease Inhibitor Cocktail: Product Overview

  2026-10-05

  K4001 is a supplier-described 50X DMSO protease inhibitor blend for conceptual protein degradation prevention during extraction, with no matched paper evidence available for product-specific performance.

• Five Questions About dNTPs and LNP Delivery

  2026-10-05

  A source-grounded guide to what a 10 mM dNTP mixture is, what recent LNP research actually shows, how strong the evidence is, and where interpretation must stop.

• HyperScribe™ Poly(A) Tailing: Research Context

  2026-10-04

  The HyperScribe™ Poly (A) Tailing Kit is described by APExBIO as an E. coli Poly (A) Polymerase-based reagent set for adding poly(A) tails to in vitro-transcribed RNA. This overview separates supplier claims from findings in a recent study of endosome-associated lc3b mRNA and local translation in neuronal axons. It explains where enzymatic polyadenylation may support conceptual expression and RNA-localization studies, while emphasizing that the supplied study did not validate this product, does not establish an optimal tail length, and cannot be used to infer clinical or therapeutic performance.

• Caspase-3 Fluorometric Assay Kit: From Signal to Mechanism

  2026-10-03

  The Caspase-3 Fluorometric Assay Kit provides a functional view of DEVD-dependent protease activity in apoptosis research. This article explains how to interpret fluorometric signals mechanistically, using renal cancer evidence to distinguish caspase activation from broader cell-death conclusions.

• Single-Molecule Screening of Fast-Dissociating Antibodies

  2026-10-02

  Miyoshi and colleagues developed a semi-automated single-molecule TIRF assay that identifies specific antibodies with unusually rapid dissociation directly from hybridoma cultures. The resulting Fab probes supported multiplex super-resolution imaging and revealed rapid espin turnover within long-lived actin cores of inner-ear stereocilia, showing that fast exchange can be experimentally useful rather than simply a loss of affinity.

• CGP 55845 Hydrochloride in Synaptic Assays

  2026-10-01

  CGP 55845 hydrochloride provides a receptor-level control for separating GABAB signaling from astrocytic GAT-3 mechanisms in dentate gyrus experiments. This guide translates the reference study into practical in vitro neurotransmission assay workflows, dose-selection logic, controls, and troubleshooting strategies.

• Homoharringtonine Workflows for Cancer Research

  2026-10-01

  Homoharringtonine connects mechanistic leukemia research with emerging SARS-CoV-2 antiviral research through selective disruption of eukaryotic protein synthesis. This practical guide covers solvent handling, assay design, controls, cross-domain interpretation, and troubleshooting for reproducible bench workflows.

• Magnetic Stimulation Targets GABRE in Schizophrenia

  2026-09-30

  The reference study identifies GABRE, encoding the GABAA receptor ε subunit, as a region-specific molecular target of selective magnetic stimulation in the left prelimbic cortex. By combining c-MSST, pharmacological modeling, genetic manipulation, behavioral testing, and synaptic analyses, the authors connect GABRE regulation with the reversal of schizophrenia-like phenotypes in mice.

• AST 487: KDM4A Inhibitor Evidence Guide

  2026-09-30

  AST 487 is a research compound used in the context of KDM4A inhibition in malignant pleural mesothelioma models. The available evidence supports a preclinical role for KDM4A blockade in reducing mesothelioma-cell growth, but it does not establish clinical efficacy, dosing, or product-specific potency.

• Novel Allosteric PDK4 Inhibitors: Study Analysis

  2026-09-29

  Jeon and colleagues developed an anthraquinone-derived series of allosteric pyruvate dehydrogenase kinase 4 inhibitors and identified compound 8c as a potent biochemical lead. The study connects enzyme inhibition with metabolic, allergic, cellular, pharmacokinetic, and docking data, while also illustrating the limits of translating preclinical PDK4 activity into therapeutic claims.

• YAP–TEAD Control of Surface Ectoderm Commitment

  2026-09-29

  A 2026 Nucleic Acids Research study maps how super-enhancer architecture and three-dimensional chromatin contacts shape early surface ectoderm commitment from pluripotent stem cells. CRISPR-dCas9 perturbation, transcription-factor network analysis, and YAP–TEAD manipulation identify TEAD activity as an upstream driver of super-enhancer establishment and lineage-associated gene activation.

• Mildronate Lipidoids for Lower-Inflammation mRNA Delivery

  2026-09-28

  A 2024 ACS Nano study developed mildronate-derived cationic lipids for low-dose lipid nanoparticles that retained effective mRNA delivery while reducing local inflammation relative to an SM102-based comparator. In prophylactic and therapeutic B16OVA melanoma models, the mLNP-69 formulation supported antitumor mRNA vaccination, providing a preclinical framework for balancing expression, immunogenicity, and tolerability.

• Apicidin Disrupts Oocyte Meiosis and Histone Acetylation

  2026-09-28

  A 2026 in-vitro study reports that Apicidin exposure delays oocyte meiotic maturation and disrupts spindle, chromosome, and actin organization. The findings connect these cellular defects with altered HDAC1/HDAC3 expression, increased acetylation of histones and α-tubulin, DNA damage, and early apoptosis, while leaving dose relevance and causality for future work.

• MK-0812 for CCR2-Dependent MASH Inflammation

  2026-09-27

  Use MK-0812 to test whether CCR2-dependent monocyte recruitment contributes to inflammation in gut–liver models—without confusing that immune-cell question with the upstream TM6SF2–LPA mechanism. This practical guide combines assay design, starting conditions, controls, and troubleshooting for a more causally informative MASH workflow.

• Homoharringtonine: Reading Antiviral Data Carefully

  2026-09-26

  Homoharringtonine is a cytotoxic alkaloid whose ribosome-targeting activity connects leukemia research with emerging antiviral questions. This article examines how to interpret the SARS-CoV-2 findings and design experiments that distinguish antiviral effects from general translation stress.

8165 records 1/545 page Next 12345 下5页 Last page